Synthesis of half-mustard combi-molecules with fluorescence properties: Correlation with EGFR status

Bioorganic and Medicinal Chemistry Letters

Volumn 15, Issue 4, 2005, Pages 1135-1138

  Rachid, Zakaria ^a   Brahimi, Fouad ^a   Domarkas, Juozas ^a   Jean Claude, Bertrand Jacques ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; QUINAZOLINE DERIVATIVE; ZR 2002; ZR 2003;

ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA DAMAGE; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; ENZYME INHIBITION; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN CELL; IC 50;

EID: 16244363334     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2004.12.015     Document Type: Article

References (23)

1. H. Meden, and W. Kuhn Eur. J. Obste. Gyne Reprod. Biol. 71 1997 173
2. H. Modjtahedi Dean. Int. J. Oncol. 4 1998 277
3. C. Xinmei, T.K. Yeung, and Z. Wang Biochem. Bioph. Res. Com. 277 2000 757
4. S.S. Hsieh, C. Malerczyk, A. Aigner, and F. Czubayko J. Cancer 86 2000 644
5. F. Giardiello, F. Caputo, R. Bianco, V. Damianco, G. Pomatico, S. De placido, A.R. Bianco, and G. Tortora Clin. Cancer Res. 6 2001 2053
6. W. Pao, V.A. Miller, E. Venkatraman, and M.G. Kris J. Nat. Cancer. Ins. 96 2004 1117
7. S.L. Matheson, J.P. McNamee, and B.J. Jean-Claude Biochem Pharmacol. 67 2004 1131
8. S.L. Matheson, J. McNamee, and B.J. Jean-Claude J. Pharmacol. Exp. Ther. 296 2001 832
9. F. Brahimi, S.L. Matheson, F. Dudouit, J.P. McNamee, A.M. Tari, and B.J. Jean-Claude J. Pharmacol. Exp. Ther. 303 2002 238 246
10. S.L. Matheson, J. McNamee, and B.J. Jean-Claude Cancer Chemother. Pharmacol. 51 2003 11 20
11. Q. Qiu, F. Dudouit, S.L. Matheson, F. Brahimi, R. Banerjee, J.P. McNamee, and B.J. Jean-Claude Cancer Chemother. Pharmacol. 51 2003 1 10
12. F. Brahimi, Z. Rachid, J.P. McNamee, Y. Li, A.M. Tari, and B.J. Jean-Claude Int. J. Cancer 112 2004 484 491
13. G.A. Roth, and J.J. Tai J. Heterocyclic Chem. 33 1996 2051 2053
14. G.W. Rewcastle, D.K. Murray, W.L. Elliott, D.W. Fry, C.T. Howard, J.M. Nelson, B.J. Roberts, P.W. Vincent, H.D. Showalter, T.R. Winters, and W.A. Denny J. Med. Chem. 41 1998 742 751
15. G.W. Rewcastle, W.A. Denny, A.J. Bridges, Z. Hairong, D.R. Cody, A. McMichael, and D.W. Fry J. Med. Chem. 38 1995 3482 3487
16. G.W. Rewcastle, A.J. Bridges, D.W. Fry, J.R. Rubin, and W.A. Denny J. Med. Chem. 40 1997 1820 1826
17. Z. Rachid, F. Brahimi, A. Katsoulas, N. Teo, and B.J. Jean-Claude J. Med. Chem. 46 2003 4313 4321
18. B. Banerejee, Z. Rachid, J. McNamee, and B.J. Jean-Claude J. Med. Chem. 46 2003 5546 5551
19. 6) d 156.4, 150.3, 147.5, 143.0, 141.9, 131.0, 129.0, 126.4, 124.9, 124.8, 121.8, 121.5, 117.1, 97.6, 45.6, 43.9
20. Z.B. Papanastassiou, R.J. Bruni, E.V. White, and P.L. Levins J. Med. Chem. 9 1966 725 729
21. D.W. Fry, A.J. Bridges, W.A. Denny, A. Doherty, K.D. Greis, J.L. Hicks, K.E. Hook, P.R. Keller, W.R. Leopold, J.A. Loo, D.J. McNamara, J.M. Nelson, V. Sherwood, J.B. Smaill, S. Trumpp-Kallmeyer, and E.M. Dobrusin Proc. Natl. Acad. Sci. U.S.A. 95 1998 12022 12027
22. L.F. Allen, P.F. Lenehan, I.A. Eiseman, W.L. Elliott, and D.W. Fry Sem. Oncol. 29 2002 11 21
23. Flow cytometric analysis: Cells were grown in 6-well plates until confluence and then incubated with ZR2002 for 30 min. Thereafter, they were harvested by trypsin-EDTA, collected by centrifugation and washed twice with PBS. Analyses were performed by flow cytometry using UV filter of 424 ± 44 nm. The following cell lines were analyzed: SF-126, SF-126-EGFR, SF-188, SF188-EGFR, MDA-MB-468, MDA-MB-231, MDA-MB-435, A431